CoCensys Inc.: The Irvine pharmaceutical company posted...

CoCensys Inc.: The Irvine pharmaceutical company posted a net loss of $16.1 million, or $1.70 a share, for the second quarter, which included a onetime, non-cash charge of $12.3 million for acquired research and development expenses related to an acquisition in June. That compares with a net loss of $2.6 million, or 29 cents a share, for the second quarter of 1993. The year-to-date loss was $20.7 million, or $2.21 a share, compared with a net loss of $4.8 million, or 56 cents a share, for the 1993 first half. No revenue was reported.